Search Results - "PATEL, Girishchandra B"

Refine Results
  1. 1

    Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection by Qiu, Hongyu, KuoLee, Rhonda, Harris, Greg, Van Rooijen, Nico, Patel, Girishchandra B, Chen, Wangxue

    Published in PloS one (29-06-2012)
    “…Acinetobacter baumannii is an emerging bacterial pathogen that causes nosocomial pneumonia and other infections. Although it is recognized as an increasing…”
    Get full text
    Journal Article
  2. 2

    Induction of mucosal immunity through systemic immunization: Phantom or reality? by Su, Fei, Patel, Girishchandra B., Hu, Songhua, Chen, Wangxue

    Published in Human vaccines & immunotherapeutics (02-04-2016)
    “…Generation of protective immunity at mucosal surfaces can greatly assist the host defense against pathogens which either cause disease at the mucosal…”
    Get full text
    Journal Article
  3. 3

    A Mouse Model of Acinetobacter baumannii-Associated Pneumonia Using a Clinically Isolated Hypervirulent Strain by HARRIS, Greg, RHONDA KUO LEE, LAM, Christopher K, KANZAKI, Gregory, PATEL, Girishchandra B, XU, H. Howard, WANGXUE CHEN

    Published in Antimicrobial Agents and Chemotherapy (01-08-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Intestinal M cells: The fallible sentinels by Miller, Harvey, Zhang, Jianbing, Kuolee, Rhonda, Patel, Girishchandra B, Chen, Wangxue

    Published in World journal of gastroenterology : WJG (14-03-2007)
    “…The gastrointestinal tract represents the largest mucosal membrane surface in the human body. The immune system in the gut is the first line of host defense…”
    Get full text
    Journal Article
  5. 5

    Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthma by Qiu, Hongyu, Kuolee, Rhonda, Harris, Greg, Zhou, Hongyan, Miller, Harvey, Patel, Girishchandra B, Chen, Wangxue

    Published in PloS one (18-07-2011)
    “…Allergic asthma is a dysregulation of the immune system which leads to the development of Th2 responses to innocuous antigens (allergens). Some infections and…”
    Get full text
    Journal Article
  6. 6

    Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge by Patel, Girishchandra B, Zhou, Hongyan, Ponce, Amalia, Harris, Greg, Chen, Wangxue

    Published in PloS one (29-12-2010)
    “…Archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) is a safe mucosal adjuvant that elicits long lasting and memory boostable mucosal and systemic…”
    Get full text
    Journal Article
  7. 7

    Recent advances in the development of novel mucosal adjuvants and antigen delivery systems by Chen, Wangxue, Patel, Girishchandra B., Yan, Hongbin, Zhang, Jianbing

    Published in Human vaccines (01-09-2010)
    “…Mucosal infections and associated diseases remain a major socio-economic burden to society. Since parenteral immunizations fail to induce efficient protective…”
    Get full text
    Journal Article
  8. 8

    Safety of Intranasally Administered Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery (AMVAD) Vaccine in Mice by Patel, Girishchandra B., Ponce, Amalia, Zhou, Hongyan, Chen, Wangxue

    Published in International journal of toxicology (01-07-2008)
    “…The safety profile of a recently described novel archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) system capable of eliciting robust…”
    Get full text
    Journal Article
  9. 9

    Intranasal immunization protects against Acinetobacter baumannii -associated pneumonia in mice by KuoLee, Rhonda, Harris, Greg, Yan, Hongbin, Xu, H. Howard, Conlan, Wayne J, Patel, Girishchandra B, Chen, Wangxue

    Published in Vaccine (01-01-2015)
    “…Highlights • Intranasal immunization protects mice against lethal respiratory Acinetobacter baumannii infection. • Immunization limits bacterial extrapulmonary…”
    Get full text
    Journal Article
  10. 10

    The Potent Adjuvant Activity of Archaeosomes Correlates to the Recruitment and Activation of Macrophages and Dendritic Cells In Vivo by Krishnan, Lakshmi, Sad, Subash, Patel, Girishchandra B, Sprott, G. Dennis

    Published in The Journal of immunology (1950) (01-02-2001)
    “…The unique glycerolipids of Archaea can be formulated into vesicles (archaeosomes) with potent adjuvant activity. We studied the effect of archaeosomes on APCs…”
    Get full text
    Journal Article
  11. 11

    Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines by Patel, Girishchandra B, Zhou, Hongyan, Ponce, Amalia, Chen, Wangxue

    Published in Vaccine (12-12-2007)
    “…Abstract The utility of archaeal polar lipids as an adjuvant/delivery system for elicitation of antigen-specific mucosal immune responses in intranasally…”
    Get full text
    Journal Article
  12. 12

    3′,5′-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection by Yan, Hongbin, KuoLee, Rhonda, Tram, Kha, Qiu, Hongyu, Zhang, Jianbing, Patel, Girishchandra B., Chen, Wangxue

    “…3′,5′-Cyclic diguanylic acid (cdiGMP) is emerging as a universal bacterial second messenger in regulating bacterial growth on surfaces. It has been recently…”
    Get full text
    Journal Article
  13. 13

    Archaeal lipid mucosal vaccine adjuvant and delivery system by Patel, Girishchandra B, Chen, Wangxue

    Published in Expert review of vaccines (01-04-2010)
    “…Archaeal polar lipids are being evaluated as adjuvants/vaccine delivery systems for mucosal vaccines that can provide protection against pathogens that enter…”
    Get more information
    Journal Article
  14. 14

    Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen by Sprott, G Dennis, Sad, Subash, Fleming, L Perry, Dicaire, Chantal J, Patel, Girishchandra B, Krishnan, Lakshmi

    Published in Archaea (2003)
    “…Archaeosomes prepared from total polar lipids extracted from six archaeal species with divergent lipid compositions had the capacity to deliver antigen for…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge by KRISHNAN, Lakshmi, SAD, Subash, PATEL, Girishchandra B, SPROTT, G. Dennis

    Published in Cancer research (Chicago, Ill.) (15-05-2003)
    “…Archaeosome adjuvants formulated as archaeal ether glycerolipid vesicles induce strong CD4(+) as well as CD8(+) CTL responses to entrapped soluble antigens…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Archaeosome Vaccine Adjuvants Induce Strong Humoral, Cell-Mediated, and Memory Responses: Comparison to Conventional Liposomes and Alum by KRISHNAN, L, DICAIRE, C. J, PATEL, G. B, SPROTT, G. D

    Published in Infection and Immunity (01-01-2000)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    Archaeosomes Induce Long-Term CD8+ Cytotoxic T Cell Response to Entrapped Soluble Protein by the Exogenous Cytosolic Pathway, in the Absence of CD4+ T Cell Help by Krishnan, Lakshmi, Sad, Subash, Patel, Girishchandra B, Sprott, G. Dennis

    Published in The Journal of immunology (1950) (01-11-2000)
    “…The unique ether glycerolipids of Archaea can be formulated into vesicles (archaeosomes) with strong adjuvant activity for MHC class II presentation. Herein,…”
    Get full text
    Journal Article
  20. 20

    Safety Evaluation of Calcium Administered Intranasally to Mice by Patel, Girishchandra B., Zhou, Hongyan, Ponce, Amalia, Chen, Wangxue

    Published in International journal of toxicology (01-11-2009)
    “…Calcium, a component of approved human vaccines administered via systemic routes, has a good safety profile. Recently, intranasally administered vaccines…”
    Get full text
    Journal Article